KEPODIL-CV DRY SYRUP
  • Share this portfolio
  • Previous Portfolio
  • Next Portfolio
  • Portfolio Detail
  • Portfolio List
  • Close Video

KEPODIL-CV DRY SYRUP

August 1, 2015

KEPODIL-CV is effective in the treatment of infections caused by penicillinase-producing strains of bacteria.

KEPODIL-CV has a broad spectrum activity as clavulanic acid extends the spectrum of antibiotics to b-lactamase producing microorganisms.

CATEGORY:

Cefopodoxime: 3rd generation oral cephalosporin
ClavulanicAcid: beta-lactamase inhibitor
MODE OF ACTION:

>  Cefpodoxime:Cefpodoxime kills bacteria by inhibiting cell wall synthesis by binding to target proteins.
>  Clavulanicacid:Inhibit beta-lactamase enzyme and is used in combination to extend the anti-bacterial spectrum.
INDICATIONS:
Post-surgicalinfection              Typhoid fever
RespiratoryTractInfections     UrinaryTract Infections
Otitis media
DOSAGE:
Adult dose: 1 Tab. (KEPODIL CV-200) 2 times in a day for 5-10 days.

Paediatric dose: 8-10mg / kg / day in two divided doses on the basis of Cefpodoxime content.

SAFETY PROFILE:
Pregnancy : Can be given.
Lactation : Given with caution.
Geriatrics : Can be given safely.

Contraindications: Hypersensitivity reactions to penicillin, cephalosporins and other beta-lactam antibiotics, beta-lactamase inhibitors or any excipient used in the formulations.
Precautions: Caution advised in patients receiving diuretics concurrently.
Adverse effects: Diarrheoa, nausea, vaginal fungal infections, vomiting, headache.